AVE Ann: Avecho receives ethics approval for Phase III CBD trial - 22nd Dec 2022, 9:52am

annb0t

annb0t

Top 20
AVE Ann: Avecho receives ethics approval for Phase III CBD trial
Price Sensitive: Y
Date: 22nd Dec 2022, 9:52am

>>> Read announcement: Google: AVE Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
AVE Ann: Avecho raises further $6M for Phase III trial - 28th Aug 2023, 10:40am
Replies
0
Views
90
annb0t
annb0t
annb0t
AVE Ann: Avecho licenses TPM for use in cancer drugs - 22nd May 2023, 9:39am
Replies
0
Views
119
annb0t
annb0t
annb0t
AVE Ann: Avecho to present at NWR Virtual Healthcare Conference - 17th Mar 2023, 9:35am
Replies
0
Views
118
annb0t
annb0t
annb0t
AVE Ann: Athenex submits Avecho's phytonadione to FDA pre-IND - 12th Jan 2023, 11:49am
Replies
0
Views
202
annb0t
annb0t
annb0t
AVE Ann: September 2023 Quarterly Activities Report & Appendix 4C - 31st Oct 2023, 9:08am
Replies
0
Views
107
annb0t
annb0t
Top Bottom